Americus Has Reverse Stock Split
- Share via
Irvine-based Americus Funding Corp. said Tuesday that it will impose a 1 for 200 reverse split of its outstanding shares of common stock, effective June 15.
The action will reduce the company’s outstanding shares of common stock to about 2.8 million.
The company also will reduce the authorized shares of common stock to 10 million. Americus is the parent of Advanced Immunotherapeutics Inc., which is developing drugs to treat various neurological and immunological diseases.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
